prof. Barbara De Moerloose
- Work address
-
Administratie Kindergeneeskunde C. Heymanslaan 10
9000 Gent - Barbara.DeMoerloose@UGent.be
- ORCID iD
-
0000-0002-2449-539X
Show
Sort by
-
- Journal Article
- A1
- open access
In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia
-
- Journal Article
- A1
- open access
The prognostic value of IKZF1(plus) in B‐cell progenitor acute lymphoblastic leukemia : results from the EORTC 58951 trial
-
- Journal Article
- A1
- open access
Measurable residual disease and fusion partner independently predict survival and relapse risk in childhood KMT2A-rearranged acute myeloid leukemia : a study by the International Berlin-Frankfurt-Münster Study Group
-
The clinical spectrum and biological findings in RAS-associated juvenile myelomonocytic leukemia and RAS-associated autoimmune leukoproliferative disorder
-
Retrospective study of children with chronic myeloid leukemia treated in Belgium between 2000 and 2021
-
- Journal Article
- A1
- open access
Management of children and adolescents with chronic myeloid leukemia in blast phase : international pediatric CML expert panel recommendations
-
- Journal Article
- A1
- open access
Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia
-
- Journal Article
- A1
- open access
In vivo stabilization of a less toxic asparaginase variant leads to a durable anti-tumor response in acute leukemia
-
- Conference Paper
- C3
- open access
Mutational permutations of a single amino acid exert divergent phenotypic effects in human, mice and cellular models of SAMD9L bone marrow failure disorder
-
- Journal Article
- A1
- open access
Three-year update of tisagenlecleucel in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia in the ELIANA trial